Breckenridge Pharmaceutical launches 10mg strength of Everolimus Tablets
4 October 2021 -

Breckenridge Pharmaceutical Inc, a United States subsidiary of Towa Pharmaceutical, announced on Friday, that it has introduced the 10mg strength of Everolimus Tablets (generic for Afinitor).

The company had previously received final approval for the Abbreviated New Drug Application for the product.

Everolimus Tablets were developed in collaboration with Natco Pharma Limited. Breckenridge had earlier launched its Everolimus tablets in 2.5mg, 5mg and 7.5mg strengths during the second quarter of 2021.



Related Headlines